Home
Storia in 3 fonti
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
- ·
cnbc.com
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
- ·
theguardian.com
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
First and only GLP-1 pill on the market costs significantly less than injectable versions
- ·
upi.com
Novo Nordisk's GLP-1 weight-loss pill now available in U.S. pharmacies - UPI.com
Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available" at U.S. pharmacies.